HIMS Stock Analysis: Buy, Sell, or Hold?
HIMS - Hims & Hers Health, Inc.
$33.94
1.23 (3.76%)
▲
5d:
-4.31%
30d:
+34.68%
90d:
+62.7%
HOLD
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Smart Money Distribution
None View Scanner →
Strength: 10.0/10
Get Alerted When HIMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HIMS trades at premium valuation expecting 6.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: HIMS trades at premium valuation expecting 6.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$14.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HIMS is currently trading at $33.94, which is considered extended relative to its 30-day fair value range of $24.41 to $31.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 50.7) compared to its historical average (42.2). At these levels, the market is pricing in 6.3% annual earnings growth.
Technical Outlook: Technically, HIMS is in a strong uptrend. Immediate support is located at $26.52, while resistance sits at $35.99. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: HIMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.32. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HIMS is in a strong uptrend. Immediate support is located at $26.52, while resistance sits at $35.99. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: HIMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.32. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.41 -
$31.85
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
Protect Your Profits
Holding HIMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BEARISH: Trading 19.5% above Wall St target ($27.32)
- BULLISH: Expecting earnings turnaround to 6.3% growth with 3.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$24.41 -
$31.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.52
Resistance Level
$35.99
Current Trend
Strong Uptrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.66
Wall Street Target
$27.32
(-19.5%)
Revenue Growth (YoY)
3.8%
Earnings Growth (YoY)
-17.4%
Profit Margin
-0.6%
Valuation Premium vs History
+6.3% premium
PE vs Historical
50.7 vs 42.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$36.08
(+6%)
2-Year Target
$38.35
(+13%)
3-Year Target
$40.77
(+20%)
3-Yr Target (if PE normalizes)
(PE: 51→42)
PE COMPRESSION
$33.96
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 28, 2026 2:22 PM ET
Data refreshes hourly during market hours. Next update: 3:22 PM
Data refreshes hourly during market hours. Next update: 3:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIMS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Soleil Boughton
SELL
9463 shares
2026-04-20
Oluyemi Okupe
SELL
19645 shares
2026-04-20
Oluyemi Okupe
SELL
18005 shares
2026-04-17
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 54 HOLD |
Advanced HIMS Option Strategies
Professional options setups generated by AI based on today's HIMS price and gamma walls.
